Information Provided By:
Fly News Breaks for June 23, 2017
BIIB
Jun 23, 2017 | 07:28 EDT
Deutsche Bank analyst Andrew Peters started Biogen with a Buy rating and $315 price target, as he sees meaningful top-line growth driven by the pipeline and recently approved products and also expects margin expansion. Peters also hold a favorable view on Biogen's pipeline optionality, he tells investors.